Found 75 results for ""

• Zentiva hosted the “European Health Check”: 77 % do not believe the framework for generic medicines is sustainable

  Key takeaways included the emerging risk of medicine shortages. This not only contradicts the solidarity principle of the European Union but also burdens the industry with added costs and administrative demands.

• Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply

  Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EU’s Critical Medicines Alliance, held on April 24-25 in Brussels.

• Meet the new Zentiva Sustainability Podcast!

  We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030.

• Acting today for a sustainable future. Discover Zentiva’s Sustainability Report 2023

  Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond.

• Top Employer 2024: Zentiva receives three certifications

  The Top Employer certification is one of the world’s most prestigious in the field of human resources management and measures each sub-activity in relation to the best industry experience.

• CPhI Worldwide Milan, come and visit us!

  From 8th to 10th October, Fiera Milano will host over 45 000 professionals against the backdrop of the most disruptive innovations in the pharmaceutical industry.

• Zentiva joins Prague.bio as first industry partner

  Prague.bio is a professional group whose main goals include the development of the biotechnology segment in the Czech Republic. Now Zentiva, has entered the Prague.bio biotechnology cluster as the first representative of the industry.

• Welcome to the April Zentiva Sustainability Podcast!

  In this episode, we welcome Sebastien Taillemite, President of Ecovamed, to discuss the topic of Green Product Design.

• Zentiva raises alarm about EU’s Urban Waste Water Treatment Directive

  The Directive might cause massive medicine shortages, affecting millions of patients across Europe.

• Why is vegetarianism healthy for our planet?

  In this episode of our Sustainability Podcast series, you will learn about the importance of vegetarian food for our health, and the environment.

• Retouren / Retours

  Information zu Retouren

• How robot bees can shape our ecosystems – listen now!

  In this episode, you will learn about data from beehive colonies turned into smart insights, helping us determine the ecological impact humans have in a certain area. In a nutshell, this AI-driven project uses bees as our smart environmental sensors to achieve sustainability goals.

• Discover Biodiversity on Zentiva’s Sustainability Podcast!

  In this episode, we welcome Vlastimil Karlík, expert from Arnika, a Czech non-profit organization. Their mission is to protect nature and a healthy environment for future generations, both at home and around the world.

• Zentiva now certified by SAP as a Customer Center of Expertise

  We are proud to announce that Zentiva has successfully achieved the SAP Customer Center of Expertise (CCoE) certification.

• Zentiva hosts strategic ESO Supplier Summit 2024 in Prague

  Zentiva and the External Supply Operations (ESO) team welcomed 25 Strategic Partners to discuss collaborative efforts for a better future.

• Squeeze-out process in Zentiva SA Romania

  Squeeze-out process in Zentiva SA Romania

• STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA

  STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA

• Speak Up initiative

  Speak Up initiative

• Whistleblowers Protection for Zentiva Group, a.s. – Czech Republic

  Whistleblowers Protection for Zentiva Group, a.s. – Czech Republic

• Information for our partners

  Information for our partners

• Steffen Saltofte, CEO of Zentiva: We are here to provide health and wellbeing for all generations

  Steffen Saltofte, CEO of Zentiva, told TIME that whatever the future holds, Zentiva has been an active leader in the pharmaceutical sector for 500 years, and it will carry on for at least the next 500.

• Therapeutic areas

  Präsentation des Produktsortiments von Zentiva für alle Haupttherapiebereiche und deren drei umsatzstärkste generische Substanzen im Schweizer Markt.

• Formulaire RGPD

  Formulaire RGPD

• Our Commitments

  Our Commitments

• Information for our partners

  Information for our partners

• Our Partnerships and Commitments to Sustainability

  At Zentiva, we understand the critical role of partnering with global initiatives and upholding the highest standards of sustainability.

• Kontakt / Contact

  Kontakt / Contact

• Preissenkungen / Réduction des prix

  Preissenkungen / Réduction des prix

• Datenschutzerklärung / Politique de confidentialité

  Datenschutzerklärung / Politique de confidentialité

• Datenschutzbeauftragter / Contact Délégué à la Protection des données

  Datenschutzbeauftragter

• DSGVO Formular / Formulaire RGPD

  DSGVO Formular / Formulaire RGPD

• We Deliver

  We Deliver

• We Produce

  We Produce

• We Care

  We Care

• Careers

  Careers @Zentiva

• Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

  Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

• Zentiva signed an investment agreement and will launch a voluntary public purchase offer for Apontis Pharma

  Zentiva signed an investment agreement and will launch a voluntary public purchase offer for Apontis Pharma

• We Develop

  We Develop

• Diversity, Equity, Inclusion & Belonging

  Diversity, Equity, Inclusion & Belonging

• Who we are

  Who we are

• What we offer

  What we offer

• Our Leadership Team

  Executive Team

• Generic FAQ

  With more than 500 products in 900 drug forms, Zentiva offers one of the broadest generic product portfolios for international markets.

• Our history

  Our History

• Allgemeine Nutzungsbedingungen

  Allgemeine Nutzungsbedingungen

• Sitemap

  Sitemap

• Cookie Policy

  Cookie Policy

• Produkte / Produits

  Mit über 500 Produkten in 900 Darreichungsformen bietet Zentiva eines der grössten Sortimente mit Generika für internationale Märkte.

• Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

  Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

• Sustainability

  Sustainability @Zentiva

• Datenschutz / RGPD

  DSGVO / RGPD

• Our Memberships

  Zentiva proudly partners with key associations to strengthen our commitment to ethical practices, regulatory compliance, and sustainable development.

• Media

  Media

• Acting today for a sustainable future. Discover Zentiva’s Sustainability Report 2022

  Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond.

• Transparenz / Transparence

  Transparenz / Transparence

• Acting today for a sustainable future. Discover Zentiva’s Sustainability Report 2021. Click here.

  Acting today for a sustainable future. Discover Zentiva’s Sustainability Report 2021. Click here.

• Home

• Zentiva Climate Targets Officially Validated by the Science-Based Targets Initiative (SBTi)

  Zentiva is proud to announce a significant step forward in its sustainability strategy with official validation of its targets by the Science Based Targets initiative (SBTi). By setting near term and long-term net-zero Green House Gas (GHG) reduction targets in line with the SBTi, this commitment reinforces Zentiva’s dedication to sustainability and aligns our decarbonisation roadmap with the European Union’s goal of becoming the first climate-neutral continent by 2050.

• Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor biosimilar medicine

  Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.

• Zentiva takes legal action and challenges Urban Wastewater Treatment Directive to protect access to affordable healthcare for millions of people in Europe

  Zentiva has filed a legal case with the Court of Justice of the European Union challenging the Urban Wastewater Treatment Directive (UWWTD) to safeguard access to affordable medicines in Europe.

• Zentiva ranked as a Top Employer in Bulgaria, Czechia and Romania

  Zentiva is delighted to announce its recognition by the Top Employers Institute as a Top Employer 2025 for the fourth consecutive year in the Czech Republic and Romania and for the second straight year in Bulgaria.

• Zentiva and Euractiv Bring Policymakers Together for Health Policy Conference: Ensuring Fair Access to Medicines for All

  Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”

• Zentiva becomes a partner of the GreenChemForCE project

  Zentiva is proud to announce that our API Development Team has joined the GreenChemForCE project, part of the Interreg CENTRAL EUROPE Programme, co-funded by the European Union.

• Zentiva is now a proud member of the Pharmaceutical Supply Chain Initiative

  Zentiva is proud to announce we have the Pharmaceutical Supply Chain Initiative (PSCI). The PSCI is a leading association for pharmaceutical and healthcare companies, driving responsible and sustainable business practices throughout the industry. By joining this initiative, Zentiva is demonstrating its commitment to upholding the highest standards in ethics, integrity, and sustainability.

• Zentiva supports the Critical Medicines Act as a welcome step forward

  Zentiva is delighted to announce its endorsement for the European Commission’s Critical Medicines Act, a crucial initiative toward ensuring the availability of essential medicines and enhancing pharmaceutical manufacturing across Europe.

• Zentiva celebrates the 2024 Parc Awards

  Initiated by Zentiva, The Parc (Pharmaceutical Applied Research Center ) provides world class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers, and managers both from academia and the pharmaceutical industry.

• Sustainable architecture in the spotlight – the latest episode of our podcast

  At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.

• Focus on Green Chemistry: the latest episode of our Sustainability podcast

  At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.

• Zentiva attended the second Forum of the Critical Medicines Alliance

  On 12 February 2025, Zentiva participated in the 2nd Critical Medicines Alliance Forum in Brussels, which gathered over 300 participants of key stakeholders to discuss recommendations for the upcoming Critical Medicines Act, scheduled to be announced in March 2025

• Science Day: Shaping the Future of Healthcare at Zentiva

  At Zentiva, we believe that innovation starts with collaboration. One of the key pillars supporting this vision is The Parc (Pharmaceutical Applied Research Center), a collaborative platform where doctoral students work alongside Zentiva experts to address real-world pharmaceutical challenges.

• Whistleblowers Protection

  Whistleblowers Protection

• Zentiva announces sale from Advent to GTCR

  Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.

• Zentiva presents its Sustainability Report 2024: Acting today for a sustainable tomorrow

  For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.